PNC Financial Services Group Inc. Cuts Stock Position in The Clorox Company (NYSE:CLX)

PNC Financial Services Group Inc. cut its position in The Clorox Company (NYSE:CLX) by 6.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 120,672 shares of the company’s stock after selling 8,315 shares during the period. PNC Financial Services Group Inc. owned 0.10% of Clorox worth $17,207,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. First National Bank of Mount Dora Trust Investment Services grew its stake in shares of Clorox by 3.2% in the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after buying an additional 71 shares during the period. Modera Wealth Management LLC lifted its stake in shares of Clorox by 1.4% in the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after purchasing an additional 71 shares during the last quarter. Czech National Bank grew its holdings in shares of Clorox by 0.3% during the 4th quarter. Czech National Bank now owns 21,718 shares of the company’s stock worth $3,097,000 after purchasing an additional 71 shares during the period. Global Retirement Partners LLC increased its position in shares of Clorox by 7.2% during the 4th quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock worth $156,000 after purchasing an additional 73 shares during the last quarter. Finally, West Branch Capital LLC raised its holdings in Clorox by 9.3% in the 4th quarter. West Branch Capital LLC now owns 903 shares of the company’s stock valued at $129,000 after buying an additional 77 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

CLX opened at $134.33 on Wednesday. The company has a 50 day moving average of $145.06 and a two-hundred day moving average of $144.95. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14. The company has a market cap of $16.68 billion, a P/E ratio of 69.60, a P/E/G ratio of 2.08 and a beta of 0.44. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.51 EPS. On average, analysts expect that The Clorox Company will post 5.83 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 10th. Investors of record on Wednesday, April 24th were issued a $1.20 dividend. The ex-dividend date was Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.57%. Clorox’s payout ratio is currently 248.71%.

Analysts Set New Price Targets

CLX has been the subject of several analyst reports. DA Davidson reissued a “neutral” rating and set a $162.00 target price on shares of Clorox in a research note on Wednesday, April 17th. Morgan Stanley reiterated an “equal weight” rating and set a $160.00 price target on shares of Clorox in a report on Tuesday, March 26th. UBS Group reduced their price objective on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Wells Fargo & Company lowered their target price on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating for the company in a research note on Thursday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft cut their price target on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research note on Wednesday, April 17th. Four investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $146.43.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.